GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Celon Pharma CLN.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

16.30

0.00%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

11 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 0Strong buy
  • 1Buy
  • 4Hold
  • 5Sell
  • 1Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 16.30Average target 17.34

Low
16.16
Average
17.34
Median
17.34
High
18.90

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenuePLN 262.4mPLN 303.5mPLN 407.0mPLN 351.7mPLN 453.7m
Revenue, highestPLN 308.3mPLN 314.3mPLN 469.7mPLN 365.7mPLN 471.7m
Revenue, lowestPLN 241.5mPLN 283.1mPLN 344.3mPLN 341.3mPLN 440.2m
Earnings per share1.950.100.75——
Earnings per share, highest2.250.110.86——
Earnings per share, lowest1.710.090.66——
Analysts53222

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 6.9% a year over 10 years. Return on equity -21.8%.

Model fair value

21.94

From earnings 21.94, from revenue 25.39.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.